What does DR. IGNACE BOELAERT do?

DR. IGNACE BOELAERT is a specialist medical practice in Dilbeek. Private Limited, started on 23 June 2005, 1 establishment.

What is the address of DR. IGNACE BOELAERT?

The registered office of DR. IGNACE BOELAERT is located at Weerstanderslaan 20, 1700 Dilbeek.

Is DR. IGNACE BOELAERT still active?

Yes. According to the CBE (15 November 2026) DR. IGNACE BOELAERT is active, legal situation “Normale toestand”, started on 23 June 2005.

Is DR. IGNACE BOELAERT registered on Peppol?

Yes, DR. IGNACE BOELAERT is registered on the Peppol network with ID 0208:0874650582.

What is the enterprise number of DR. IGNACE BOELAERT?

The enterprise number of DR. IGNACE BOELAERT is BE0874650582.

When was DR. IGNACE BOELAERT founded?

DR. IGNACE BOELAERT was founded on 23 June 2005.

Who are the directors of DR. IGNACE BOELAERT?

According to the 2025 annual accounts, the directors of DR. IGNACE BOELAERT are: Ignace Boelaert.

Is DR. IGNACE BOELAERT a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 23 June 2005; 4 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account; 2 events from the Belgian Official Gazette processed.

How much profit did DR. IGNACE BOELAERT make in 2025?

DR. IGNACE BOELAERT posted a profit after taxes of € 555,304 in financial year 2025.

What is the revenue of DR. IGNACE BOELAERT?

As a small company, DR. IGNACE BOELAERT is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 799,536.

DR. IGNACE BOELAERT (Private Limited) - Dilbeek

Dossier DR. IGNACE BOELAERT, printed on 15 November 2026 from databakkes.be/en/0874650582/dr-ignace-boelaert. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

DR. IGNACE BOELAERT from Dilbeek, company number BE0874650582, closed financial year 2025 with a result of € 555,304 after tax. For that financial year DR. IGNACE BOELAERT recorded a gross margin of € 799,536 and equity of € 4.5 million. Compared with financial year 2024, the result moved from € 550,543 to € 555,304. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on January 5, 2026.

What it is worth Growing

€ 4.5 million

▲ 7% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 555,304

▲ 1% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 302,390

▲ 98% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 279,367 paid out

50 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Vehicles and equipment

€ 24,187

▼ 46% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 4,247

▲ 130% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 12,597

▼ 62% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 870,244 Gross margin 2022: € 870,244 First fiscal year in the series	€ 897,095 Gross margin 2023: € 897,095 ▲ 3% vs 2022 (€ 870,244) Favourable step	€ 837,028 Gross margin 2024: € 837,028 ▼ 7% vs 2023 (€ 897,095) Unfavourable step	€ 799,536 Gross margin 2025: € 799,536 ▼ 4% vs 2024 (€ 837,028) Unfavourable step	▼ 4%
Profit after taxes	€ 790,857 Profit after taxes 2022: € 790,857 First fiscal year in the series	€ 586,893 Profit after taxes 2023: € 586,893 ▼ 26% vs 2022 (€ 790,857) Unfavourable step	€ 550,543 Profit after taxes 2024: € 550,543 ▼ 6% vs 2023 (€ 586,893) Unfavourable step	€ 555,304 Profit after taxes 2025: € 555,304 ▲ 1% vs 2024 (€ 550,543) Favourable step	▲ 1%
Equity	€ 3,298,970 Equity 2022: € 3,298,970 First fiscal year in the series	€ 3,668,067 Equity 2023: € 3,668,067 ▲ 11% vs 2022 (€ 3,298,970) Favourable step	€ 4,218,610 Equity 2024: € 4,218,610 ▲ 15% vs 2023 (€ 3,668,067) Favourable step	€ 4,494,547 Equity 2025: € 4,494,547 ▲ 7% vs 2024 (€ 4,218,610) Favourable step	▲ 7%
Total debts	€ 770,163 Total debts 2022: € 770,163 First fiscal year in the series	€ 603,168 Total debts 2023: € 603,168 ▼ 22% vs 2022 (€ 770,163) Favourable step	€ 421,857 Total debts 2024: € 421,857 ▼ 30% vs 2023 (€ 603,168) Favourable step	€ 427,489 Total debts 2025: € 427,489 ▲ 1% vs 2024 (€ 421,857) Unfavourable step	▲ 1%
Cash	€ 221,845 Cash 2022: € 221,845 First fiscal year in the series	€ 162,295 Cash 2023: € 162,295 ▼ 27% vs 2022 (€ 221,845) Unfavourable step	€ 152,859 Cash 2024: € 152,859 ▼ 6% vs 2023 (€ 162,295) Unfavourable step	€ 302,390 Cash 2025: € 302,390 ▲ 98% vs 2024 (€ 152,859) Favourable step	▲ 98%
Land & buildings	€ 9,903 Land & buildings 2022: € 9,903 First fiscal year in the series	€ 8,355 Land & buildings 2023: € 8,355 ▼ 16% vs 2022 (€ 9,903) Unchanged	€ 50,724 Land & buildings 2024: € 50,724 ▲ € 42,368 vs 2023 (€ 8,355) Unchanged	€ 46,166 Land & buildings 2025: € 46,166 ▼ 9% vs 2024 (€ 50,724) Unchanged	▼ 9%
Retained profit	€ 3,278,970 Retained profit 2022: € 3,278,970 First fiscal year in the series	€ 3,648,067 Retained profit 2023: € 3,648,067 ▲ 11% vs 2022 (€ 3,278,970) Favourable step	€ 4,198,610 Retained profit 2024: € 4,198,610 ▲ 15% vs 2023 (€ 3,648,067) Favourable step	€ 4,474,547 Retained profit 2025: € 4,474,547 ▲ 7% vs 2024 (€ 4,198,610) Favourable step	▲ 7%
Dividend	€ 237,482 Dividend 2022: € 237,482 First fiscal year in the series	€ 217,796 Dividend 2023: € 217,796 ▼ 8% vs 2022 (€ 237,482) Unchanged	€ 0 Dividend 2024: € 0 ▼ 100% vs 2023 (€ 217,796) Unchanged	€ 279,367 Dividend 2025: € 279,367 Unchanged (€ 0) Unchanged
Balance sheet total	€ 4,069,132 Balance sheet total 2022: € 4,069,132 First fiscal year in the series	€ 4,271,235 Balance sheet total 2023: € 4,271,235 ▲ 5% vs 2022 (€ 4,069,132) Unchanged	€ 4,640,466 Balance sheet total 2024: € 4,640,466 ▲ 9% vs 2023 (€ 4,271,235) Unchanged	€ 4,922,035 Balance sheet total 2025: € 4,922,035 ▲ 6% vs 2024 (€ 4,640,466) Unchanged	▲ 6%

By gross margin, DR. IGNACE BOELAERT ranks 2nd of 21 companies with main activity “Activiteiten van medisch specialisten” in Dilbeek that publish figures (fiscal year 2025).

Key figures of DR. IGNACE BOELAERT, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 January 2027.

Ask about DR. IGNACE BOELAERT the way you would ask their accountant.

Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.

Connect ChatGPT or Claude for free

ChatGPT
Claude

Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.

What happened to DR. IGNACE BOELAERT?

What happened at DR. IGNACE BOELAERT in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jan 5, 2026 New annual accounts for financial year 2025: profit of € 555,304 (▲ 1% vs 2024). Source: NBB ↗
Jun 24, 2014 Capital increase of € 530,000, published in the Gazette. Source: Staatsblad ↗
Jul 1, 2005 Incorporation, published in the Gazette. Source: Staatsblad ↗
Jun 24, 2005 New establishment in Dilbeek. KBO
2005 Ignace Boelaert became a director. NBB